UNCY earnings: a positive outcome, +33.9%

On August 14, 2024, Unicycive Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +33.9% in the window around the event. It had already run -28.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.